{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:04:30Z","timestamp":1774663470375,"version":"3.50.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005992","name":"Ministry of Education and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki Rzeczypospolitej Polskiej","doi-asserted-by":"publisher","award":["SKN\/SP\/570108\/2023"],"award-info":[{"award-number":["SKN\/SP\/570108\/2023"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110858","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:19:07Z","timestamp":1694517547000},"page":"110858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"PA","title":["Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI"],"prefix":"10.1016","volume":"124","author":[{"given":"Dominik","family":"Felkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Zi\u0119ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Kaleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Czaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Zyzdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiktoria","family":"Soboci\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Jarczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Bryniarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-117X","authenticated-orcid":false,"given":"Katarzyna","family":"Nazimek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","article-title":"Metabolism of tissue macrophages in homeostasis and pathology","volume":"19","author":"Wculek","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110858_b0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110858_b0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/ijms19010092","article-title":"The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis","volume":"19","author":"Hirayama","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110858_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases","volume":"165\u2013166","author":"He","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2023.110858_b0030","first-page":"1","article-title":"Inflammatory mechanisms in the lung","volume":"2","author":"Moldoveanu","year":"2009","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2023.110858_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119010","article-title":"Monocytes and macrophages in COVID-19: Friends and foes","volume":"269","author":"Meidaninikjeh","year":"2021","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.intimp.2023.110858_b0040","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/cns.13899","article-title":"Phagocytic microglia and macrophages in brain injury and repair","volume":"28","author":"Yu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2023.110858_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: A comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20210679","article-title":"Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression","volume":"136","author":"Kolesnikoff","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.intimp.2023.110858_b0055","doi-asserted-by":"crossref","first-page":"2795090","DOI":"10.1155\/2016\/2795090","article-title":"The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2023.110858_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/851252","article-title":"Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis","volume":"2015","author":"Rojas","year":"2015","journal-title":"Scientifica (Cairo)."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and Metabolism in the Tumor Microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2023.110858_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2016.12.032","article-title":"Nanomedicines for dysfunctional macrophage-associated diseases","volume":"247","author":"He","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2023.110858_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.577559","article-title":"Emerging Evasion Mechanisms of Macrophage Defenses by Pathogenic Bacteria","volume":"10","author":"Leseigneur","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39898-5","article-title":"HIV infection and latency induce a unique metabolic signature in human macrophages","volume":"9","author":"Castellano","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","article-title":"Macrophages in tuberculosis: Friend or foe","volume":"35","author":"Guirado","year":"2013","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0095","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0001-2019","article-title":"Mycobacterium tuberculosis: Bacterial fitness within the host macrophage","volume":"7","author":"Huang","year":"2019","journal-title":"Microbiol Spectr."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.00812-20","article-title":"Nontuberculous mycobacteria, macrophages, and host innate immune response","volume":"89","author":"Shamaei","year":"2021","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonz\u00e1lez-Scarano","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00291-21","article-title":"Macrophages in Microbial Pathogenesis: Commonalities of Defense Evasion Mechanisms","volume":"90","author":"Pandey","year":"2022","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0115","doi-asserted-by":"crossref","first-page":"e02415","DOI":"10.1128\/JVI.02415-20","article-title":"SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells","volume":"95","author":"Rebendenne","year":"2021","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41577-020-0317-2","article-title":"Macrophages: a Trojan horse in COVID-19?","volume":"20","author":"Park","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7847","key":"10.1016\/j.intimp.2023.110858_b0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110858_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113287","article-title":"The immunomodulatory effects of antihypertensive therapy: A review","volume":"153","author":"Felkle","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2023.110858_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2022.01.001","article-title":"Pulmonary macrophages and SARS-Cov2 infection","volume":"367","author":"Bain","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110858_b0140","doi-asserted-by":"crossref","first-page":"e1010479","DOI":"10.1371\/journal.ppat.1010479","article-title":"CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces proinflammatory responses","volume":"18","author":"Jalloh","year":"2022","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0145","article-title":"Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation","volume":"6","author":"Gao","year":"2022","journal-title":"Adv Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0150","doi-asserted-by":"crossref","first-page":"2102725","DOI":"10.1183\/13993003.02725-2021","article-title":"Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages","volume":"60","author":"H\u00f6nzke","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-022-01106-8","article-title":"Alveolar macrophages: Achilles\u2019 heel of SARS-CoV-2 infection","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2023.110858_b0160","article-title":"SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages","volume":"14(674):eabm9151","author":"Mart\u00ednez-Col\u00f3n","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"7914","key":"10.1016\/j.intimp.2023.110858_b0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0170","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41423-021-00665-0","article-title":"Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm","volume":"18","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"26","key":"10.1016\/j.intimp.2023.110858_b0175","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2023.110858_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109810","article-title":"The role of ACEIs\/ARBs in COVID-19: Friend or foe?","volume":"142","author":"Zhou","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ajh\/hpac001","article-title":"Effects of Renin-Angiotensin System Inhibitors on Mortality and Disease Severity of COVID-19 Patients: A Meta-analysis of Randomized Controlled Trials","volume":"35","author":"Yin","year":"2022","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13643-021-01802-6","article-title":"Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality","volume":"10","author":"Fernando","year":"2021","journal-title":"Syst. Rev."},{"issue":"17","key":"10.1016\/j.intimp.2023.110858_b0195","doi-asserted-by":"crossref","first-page":"e026143","DOI":"10.1161\/JAHA.122.026143","article-title":"Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension","volume":"11","author":"Gnanenthiran","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.intimp.2023.110858_b0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/clc.23836","article-title":"Safety of ACEi and ARB in COVID-19 management: A retrospective analysis","volume":"45","author":"Kumar","year":"2022","journal-title":"Clin. Cardiol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0205","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1111\/bcp.15331","article-title":"Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials","volume":"88","author":"Asiimwe","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2023.110858_b0210","doi-asserted-by":"crossref","first-page":"e25532","DOI":"10.1097\/MD.0000000000025532","article-title":"The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis","volume":"100","author":"Qiu","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0215","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.18632\/aging.202902","article-title":"Does taking an angiotensin inhibitor increase the risk for COVID-19? - a systematic review and meta-analysis","volume":"13","author":"Ma","year":"2021","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ehjcvp\/pvaa064","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"7","author":"Grover","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.intimp.2023.110858_b0225","doi-asserted-by":"crossref","unstructured":"Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, et al. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021;72(11):e901-e913. https:\/\/doi.org\/10.1093\/cid\/ciaa1592.","DOI":"10.1093\/cid\/ciaa1592"},{"issue":"11","key":"10.1016\/j.intimp.2023.110858_b0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.11622\/smedj.2020159","article-title":"Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality among patients with COVID-19: A systematic review and meta-Analysis","volume":"62","author":"Cai","year":"2021","journal-title":"Singapore Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0235","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1038\/s41598-021-84678-9","article-title":"Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis","volume":"11","author":"Biswas","year":"2021","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.intimp.2023.110858_b0240","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: A meta-analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0245","doi-asserted-by":"crossref","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.dsx.2020.06.047","article-title":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis","volume":"14","author":"Pranata","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.intimp.2023.110858_b0255","doi-asserted-by":"crossref","first-page":"0002","DOI":"10.34133\/hds.0002","article-title":"Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping","volume":"2022","author":"Duvvuri","year":"2022","journal-title":"Health Data Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0260","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/fampra\/cmac094","article-title":"Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people","volume":"40","author":"Dambha-Miller","year":"2023","journal-title":"Fam. Pract."},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0265","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11845-022-03096-6","article-title":"The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19","volume":"192","author":"Najafi","year":"2023","journal-title":"Ir. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102484","article-title":"Association of statin and\/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study","volume":"16","author":"Harris","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.intimp.2023.110858_b0275","doi-asserted-by":"crossref","unstructured":"Zhang X, Yu J, Pan L ya, Jiang H yin. ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis. Pharmacol Res. 2020;158:104927. https:\/\/doi.org\/10.1016\/j.phrs.2020.104927.","DOI":"10.1016\/j.phrs.2020.104927"},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40256-020-00439-5","article-title":"Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis","volume":"20","author":"Hasan","year":"2020","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.intimp.2023.110858_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100040","article-title":"Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19","volume":"9","author":"Wang","year":"2023","journal-title":"Am J Med Open."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0290","doi-asserted-by":"crossref","first-page":"e0280280","DOI":"10.1371\/journal.pone.0280280","article-title":"Systematic review and meta-analysis of the clinical outcomes of ACEI\/ARB in East-Asian patients with COVID-19","volume":"18","author":"Huang","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2023.110858_b0295","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.medcli.2021.04.005","article-title":"Chronic use of renin\u2013angiotensin\u2013aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis","volume":"158","author":"Aparisi","year":"2022","journal-title":"Med. Clin. (Barc.)"},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0300","doi-asserted-by":"crossref","first-page":"e001353","DOI":"10.1136\/openhrt-2020-001353","article-title":"Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: Systematic review and meta-analysis","volume":"7","author":"Ssentongo","year":"2020","journal-title":"Open Heart."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0305","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jjcc.2020.10.015","article-title":"Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis","volume":"77","author":"Ren","year":"2021","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0310","doi-asserted-by":"crossref","first-page":"2002964","DOI":"10.1183\/13993003.02964-2020","article-title":"Prognostic factors for adverse outcomes in patients with COVID-19: A field-wide systematic review and meta-analysis","volume":"59","author":"Bellou","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0315","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40292-023-00579-0","article-title":"Discontinuation of Antihypertensive Drug Use Compared to Continuation in COVID-19 Patients: A Systematic Review with Meta-analysis and Trial Sequential Analysis","volume":"30","author":"Chambergo-Michilot","year":"2023","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12879-023-07994-7","article-title":"Effect of continuing the use of renin-angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"19","key":"10.1016\/j.intimp.2023.110858_b0325","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.intimp.2023.110858_b0330","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-020-01101-w","article-title":"Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities","volume":"22","author":"Patoulias","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2023.110858_b0335","doi-asserted-by":"crossref","first-page":"e0288338","DOI":"10.1371\/journal.pone.0288338","article-title":"Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension","volume":"18","author":"Elbasan","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ehjcvp\/pvaa138","article-title":"Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: Systematic review and meta-analysis","volume":"8","author":"Lee","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0345","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jinf.2020.05.052","article-title":"Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis","volume":"81","author":"Pirola","year":"2020","journal-title":"J. Infect."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0350","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110858_b0355","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.21037\/apm-21-972","article-title":"The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"11","author":"Xie","year":"2022","journal-title":"Ann. Palliat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0360","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jcpt.13246","article-title":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis","volume":"45","author":"Barochiner","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.110858_b0365","doi-asserted-by":"crossref","DOI":"10.1177\/1470320320981321","article-title":"Effects of ACEI and ARB on COVID-19 patients: A meta-analysis","volume":"21","author":"Xue","year":"2020","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0370","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/HYPERTENSIONAHA.120.15989","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis","volume":"76","author":"Chan","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0375","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12879-021-06088-6","article-title":"Comparison of renin\u2013angiotensin\u2013aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes","volume":"21","author":"Bezabih","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.intimp.2023.110858_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and Macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110858_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682871","article-title":"The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome","volume":"12","author":"Kosyreva","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/joim.13559","article-title":"Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity","volume":"293","author":"Falck-Jones","year":"2023","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110858_b0395","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/01902149209064338","article-title":"Alveolar and interstitial macrophage populations in the murine lung","volume":"18","author":"Crowell","year":"1992","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.intimp.2023.110858_b0400","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2020.01312","article-title":"The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?","volume":"11","author":"Abassi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110858_b0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.thromres.2022.03.022","article-title":"Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?","volume":"213","author":"Ghasemzadeh","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2023.110858_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118617","article-title":"Preventing the development of severe COVID-19 by modifying immunothrombosis","volume":"264","author":"Morris","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2023.110858_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991991","article-title":"The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection","volume":"13","author":"Barreto-Duran","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110858_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118102","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions","volume":"257","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0425","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000521317","article-title":"Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans","volume":"101","author":"Br\u00e4utigam","year":"2022","journal-title":"Respiration"},{"key":"10.1016\/j.intimp.2023.110858_b0430","doi-asserted-by":"crossref","first-page":"1008285","DOI":"10.3389\/fimmu.2022.1008285","article-title":"Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0435","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41421-021-00258-1","article-title":"Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages","volume":"7","author":"Lv","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.intimp.2023.110858_b0440","doi-asserted-by":"crossref","first-page":"1117548","DOI":"10.3389\/fimmu.2023.1117548","article-title":"The role of immunometabolism in macrophage polarization and its impact on acute lung injury\/acute respiratory distress syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0445","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12931-018-0777-0","article-title":"Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state","volume":"19","author":"Mitsi","year":"2018","journal-title":"Respir Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0450","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0455","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12985-020-01415-w","article-title":"Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents","volume":"17","author":"Khadke","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.intimp.2023.110858_b0460","doi-asserted-by":"crossref","unstructured":"Dalskov L, M\u00f8hlenberg M, Thyrsted J, Blay\u2010Cadanet J, Poulsen ET, Folkersen BH, et al. SARS\u2010CoV\u20102 evades immune detection in alveolar macrophages. EMBO Rep. 2020;21(12):e51252. https:\/\/doi.org\/10.15252\/embr.202051252.","DOI":"10.15252\/embr.202051252"},{"issue":"7914","key":"10.1016\/j.intimp.2023.110858_b0465","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110858_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2022.100136","article-title":"Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19","volume":"15","author":"Ravichandran","year":"2022","journal-title":"Med Drug Discov."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0475","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/vaccines9050436","article-title":"Role of inflammatory cytokines in covid-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm","volume":"9","author":"Rabaan","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.intimp.2023.110858_b0480","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"20","key":"10.1016\/j.intimp.2023.110858_b0485","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.3390\/ijms232012404","article-title":"Monocyte and Macrophage Function Diversity","volume":"23","author":"Kloc","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0490","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2023.110858_b0495","doi-asserted-by":"crossref","first-page":"9028969","DOI":"10.1155\/2022\/9028969","article-title":"Exploring the Impact of ACE Inhibition in Immunity and Disease","volume":"2022","author":"Oosthuizen","year":"2022","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.intimp.2023.110858_b0500","article-title":"AT1R Regulates Macrophage Polarization Through YAP and Regulates Aortic Dissection Incidence","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0505","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms23031772","article-title":"Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs - Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers","volume":"23","author":"Bryniarski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110858_b0510","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3389\/fimmu.2020.01455","article-title":"Toll-Like Receptor 4 (TLR4)\/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110858_b0515","series-title":"Encyclopedia of Respiratory Medicine, Four-Volume Set","first-page":"343","article-title":"CD14","author":"Tesfaigzi","year":"2006"},{"key":"10.1016\/j.intimp.2023.110858_b0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cytogfr.2019.06.003","article-title":"CD14: Biology and role in the pathogenesis of disease","volume":"48","author":"Wu","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2023.110858_b0525","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/fmb-2021-0018","article-title":"Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: A proposed approach to SARS-CoV-2 treatment","volume":"16","author":"Kate Gadanec","year":"2021","journal-title":"Future Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110858_b0530","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2023.110858_b0535","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2021.10.029","article-title":"Angiotensin converting enzyme (ACE)","volume":"524","author":"Khurana","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0540","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI66541","article-title":"Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer\u2019s-like cognitive decline","volume":"124","author":"Bernstein","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0545","doi-asserted-by":"crossref","first-page":"1836766","DOI":"10.1080\/2162402X.2020.1836766","article-title":"Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1\/PD-L1 immune checkpoint blockers","volume":"9","author":"Medjebar","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2023.110858_b0550","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.trsl.2017.10.011","article-title":"Macrophages under pressure: the role of macrophage polarization in hypertension","volume":"191","author":"Harwani","year":"2018","journal-title":"Transl. Res."},{"issue":"13","key":"10.1016\/j.intimp.2023.110858_b0555","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.3390\/ijms22136702","article-title":"Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD","volume":"22","author":"Poznyak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0560","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/cells9030584","article-title":"Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis","volume":"9","author":"Poznyak","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0565","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ndt\/gfw206","article-title":"Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease","volume":"32","author":"Trojanowicz","year":"2017","journal-title":"Nephrol. Dial Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0570","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/ijms23010074","article-title":"Captopril combined with furosemide or hydrochlorothiazide affects macrophage functions in mouse contact hypersensitivity response","volume":"23","author":"Bryniarski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.intimp.2023.110858_b0575","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.3390\/ijms222111374","article-title":"Anti-inflammatory activities of captopril and diuretics on macrophage activity in mouse humoral immune response","volume":"22","author":"Bryniarski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2023.110858_b0580","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/02770909909055418","article-title":"Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages","volume":"36","author":"Suzuki","year":"1999","journal-title":"J. Asthma"},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0585","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ijo.2011.95","article-title":"Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL\/6J mice","volume":"36","author":"Premaratna","year":"2012","journal-title":"Int J Obes."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0590","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2013.11.005","article-title":"Enalapril inhibits nuclear factor-\u03baB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice","volume":"95","author":"Lee","year":"2014","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.110858_b0595","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/rheumatology\/ken208","article-title":"Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus - Results from LUMINA (LIX): A multiethnic US cohort","volume":"47","author":"Dur\u00e1n-Barrag\u00e1n","year":"2008","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110858_b0600","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1523-1755.2004.00462.x","article-title":"An ACE inhibitor reduces Th2 cytokines and TGF-\u03b21 and TGF-\u03b22 isoforms in murine lupus nephritis","volume":"65","author":"De Albuquerque","year":"2004","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0605","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.intimp.2015.01.003","article-title":"Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy","volume":"25","author":"Cucak","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110858_b0610","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00365513.2021.1892817","article-title":"The understanding of the immunopathology in COVID-19 infection","volume":"81","author":"Tascioglu","year":"2021","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0615","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41371-020-0387-4","article-title":"Covid-19 and the cardiovascular system: a comprehensive review","volume":"35","author":"Azevedo","year":"2021","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.intimp.2023.110858_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728896","article-title":"SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril)","volume":"12","author":"Barhoumi","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0625","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10741-019-09837-7","article-title":"Angiotensin II and angiotensin 1\u20137: which is their role in atrial fibrillation?","volume":"25","author":"Mascolo","year":"2020","journal-title":"Heart Fail. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2023.110858_b0630","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2023.110858_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0640","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1440-1681.2009.05302.x","article-title":"Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors","volume":"37","author":"Huang","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2023.110858_b0645","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40885-020-00147-x","article-title":"The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms","volume":"26","author":"McLachlan","year":"2020","journal-title":"Clin Hypertens."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0650","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.arcmed.2007.07.010","article-title":"ACE2 Overexpression Inhibits Angiotensin II-induced Monocyte Chemoattractant Protein-1 Expression in Macrophages","volume":"39","author":"Guo","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.intimp.2023.110858_b0655","first-page":"2401081","article-title":"Angiotensin-(1\u20137) and Alamandine Promote Anti-inflammatory Response in Macrophages in Vitro and in Vivo","volume":"2019","author":"De Carvalho","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2023.110858_b0660","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1\u20137) decreases LPS-induced inflammatory response in macrophages","volume":"227","author":"Souza","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0665","doi-asserted-by":"crossref","first-page":"e147819","DOI":"10.1172\/jci.insight.147819","article-title":"Angiotensin-(1\u20137)\/MasR axis promotes migration of monocytes\/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis","volume":"7","author":"Zaidan","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0670","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41598-020-79902-x","article-title":"Angiotensin-(1\u20137) treatment blocks lipopolysaccharide-induced organ damage, platelet dysfunction, and IL-6 and nitric oxide production in rats","volume":"11","author":"Tsai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110858_b0675","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2020.00317","article-title":"ACE2, Much More Than Just a Receptor for SARS-COV-2","volume":"10","author":"Samavati","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2023.110858_b0680","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.798349","article-title":"Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice","volume":"13","author":"Brooks","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110858_b0685","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cyto.a.24285","article-title":"Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages","volume":"103","author":"Song","year":"2023","journal-title":"Cytometry A"},{"key":"10.1016\/j.intimp.2023.110858_b0690","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abq1366","article-title":"Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release","author":"Labzin","year":"2023167821366","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2023.110858_b0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683800","article-title":"SARS-CoV-2\/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages","volume":"12","author":"Pantazi","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0700","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awz364","article-title":"Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease","volume":"143","author":"Koronyo-Hamaoui","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.intimp.2023.110858_b0705","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jamacardio.2020.1874","article-title":"Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Thomas","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.intimp.2023.110858_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115370","article-title":"Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic","volume":"208","author":"Chen","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110858_b0715","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"23","key":"10.1016\/j.intimp.2023.110858_b0720","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial","volume":"323","author":"Thomas","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2023.110858_b0725","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837524","article-title":"Trained Immunity: An Overview and the Impact on COVID-19","volume":"13","author":"Brueggeman","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110858_b0730","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1038\/s41467-023-39341-4","article-title":"In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting","volume":"14","author":"Tu","year":"2023","journal-title":"Nat. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:20Z","timestamp":1761588500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923011839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":146,"alternative-id":["S1567576923011839"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110858","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110858"}}